Search results
Results from the WOW.Com Content Network
Fluorescent glucose biosensors are devices that measure the concentration of glucose in diabetic patients by means of sensitive protein that relays the concentration by means of fluorescence, an alternative to amperometric sension of glucose. Due to the prevalence of diabetes, it is the prime drive in the construction of fluorescent biosensors.
He is most well known as the inventor of the Clark electrode, a device used for measuring oxygen in blood, water and other liquids. [2] Clark is considered the "father of biosensors", and the modern-day glucose sensor used daily by millions of diabetics is based on his research. He conducted pioneering research on heart-lung machines in the ...
A common example of a commercial biosensor is the blood glucose biosensor, which uses the enzyme glucose oxidase to break blood glucose down. In doing so it first oxidizes glucose and uses two electrons to reduce the FAD (a component of the enzyme) to FADH 2. This in turn is oxidized by the electrode in a number of steps.
The Clark oxygen electrode laid the basis for the first glucose biosensor (in fact the first biosensor of any type), invented by Clark and Lyons in 1962. [6] This sensor used a single Clark oxygen electrode coupled with a counter-electrode. As with the Clark electrode, a permselective membrane covers the Pt electrode.
Electrochemical aptamer-based (E-AB) biosensors is a device that takes advantage of the electrochemical and biological properties of aptamers to take real time, in vivo measurements. An electrochemical aptamer-based (E-AB) biosensor generates an electrochemical signal in response to specific target binding in vivo [ 3 ] The signal is measured ...
In amperometric biosensors, an enzyme-catalyzed redox reaction causes a redox electron current that is measured by a working electrode. [11] Amperometric biosensors have been used in bio-MEMS for detection of glucose, galactose, lactose, urea, and cholesterol, as well as for applications in gas detection and DNA hybridization. [11]
GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real time. The GlySens ICGM system is the world's first surgically implanted continuous glucose monitoring system to demonstrate an 18-month ...
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood . Particularly important in diabetes management , a blood glucose test is typically performed by piercing the skin (typically, via fingerstick ) to draw blood, then applying the blood to a chemically active disposable 'test-strip'.